Their roadside and home kit bundle deals combine reliable lighting and power gear that could save a life—or at least, help ...

We are still very early in the season, so the balancing act between being aggressive and picking up players off the wire ...

And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

"His expertise and clinical practice focus in carotid intervention and peripheral vascular disease offer valuable insights as we launch CGuard Prime into the U.S. market. Dr. Soukas has been a strong ...

For decades, Sri Lanka has waged cyclical wars on drugs — each beginning with zeal, arrests, and television footage, only to ...

Neoliv is currently raising its maiden fund of ₹1,000 crore. It has raised ₹750 crore so far. The second fund, of ₹2,000 crore, will be launched in FY27.

The real question is no longer “How much was spent?” but “What difference did it make?” ...

TV18's HealthX Elevate, ten ventures showed how India’s toughest constraints are driving the next generation of global health ...

Once delisted and dismissed by the ASX, Animoca Brands is now set for a Nasdaq debut through a reverse merger thanks to Trump ...

Amid unprecedented scientific progress in oncology, a growing body of evidence reveals a parallel and profound crisis in the ...

With the launch of the Recana system ... FLEX VP is designed to optimise vessel preparation and access management ahead of peripheral arterial disease (PAD) and arteriovenous fistulas and graft ...

Francesca Orsini's deportation from India highlights a troubling trend of silencing intellectual voices. Her research delved into the rich, multilingual roots of Hindi literature, challenging the ...